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Abstract.  The yeast RNA/gene is required for RNA 
processing and nuclear transport of RNA. The rnal-1 
mutation of this locus causes defects in pre-tRNA 
splicing, processing of the primary pre-rRNA tran- 
script, production of mRNA and export of RNA from 
the nucleus to the cytosol. To understand how this 
gene product can pleiotropically affect these processes, 
we sought to determine the intracellular location of 
the RNA1 protein. As determined by indirect im- 
munofluorescence localization and organelle fraction- 
ation, the RNA1 antigen is found exclusively or pri- 
marily in the cytoplasm. Only a tiny fraction of the 
endogenous protein could be localized to and func- 
tional in the nucleus. Furthermore, the RNA1 antigen 
does not localize differently under stress conditions. 
These findings suggest that the RNA1 protein is not 
directly involved  in RNA processing but may modify 
nuclear proteins or otherwise transmit a signal from 
the cytosol to the nucleus or play a role in maintain- 
ing the integrity of the nucleus. 
t:KAaVOTIC  genes are generally transcribed as precur- 
sor RNAs (pre-RNAs) that are processed to mature 
RNA species. Processing consists of  removal of  extra 
5', 3', or intervening sequences as well as addition of nucleo- 
tides and modification of nucleosides. With the exceptions of 
processing 20S pre-rRNA to mature 18S rRNA (for review 
see Warner, 1989), and addition of some modifications of  the 
anticodon loop of tRNAs (for review see Bjork et al., 1987) 
all  processing  steps  appear  to  occur before  transport  of 
RNAs from the nuclear to the cytosolic compartments. 
The gene products that participate in RNA processing are 
largely undescribed. However,  the approaches of purifica- 
tion of  enzyme activities (for example Phizicky et al., 1986), 
use of  autoimmune sera (for review see Padgett et al., 1986), 
and identification of mutations of yeast that block particular 
processing steps (for review see Woolford, 1989; Culbertson 
and Winey, 1989) have all contributed to a rapidly growing 
identification and understanding of  these gene products. Our 
work concerns the characterization of the wild-type counter- 
part of yeast genes identified by mutation. 
Many Saccharomyces cerevisiae genes encoding products 
necessary  for the processing  of mature RNA species have 
been  identified  among  collections  of conditionally  lethal 
yeast mutants (HartweU et al.,  1967; Vijayraghavan et al., 
1989). The prp2-prp11 alleles (Rosbash et al., 1981; Fried 
et al., 1981; previously these alleles were designated rna2- 
rna11), prp14 (Couto et al., 1987) and several of the prpl7- 
prp271esions (Vijayraghavan et al., 1989) affect removal of 
intervening sequences from pre-mRNAs. Many of the PRP 
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genes encode proteins that either affect the assembly of pre- 
mRNA onto spliceosomes (Lin et al., 1987) or are compo- 
nents of snRNPs and presumably  spliceosomes (Lossky et 
al., 1987; Chang et al., 1988; Bjorn et al., 1989; Banroques 
and Abelson,  1989). The protein products of some of these 
genes have been localized to the nucleus (Chang et al., 1988; 
Last and Woolford, 1986). 
The RNA/gene resembles the PRP genes in that a muta- 
tion of this gene, rna/-1, affects RNA processing.  There is 
also genetic evidence that relates the RNA/gene to the PRP 
genes because mutations  of the SRN1 locus suppress phe- 
notypes of some of the prp mutations as well as the rna/-1 
mutation (Pearson et al., 1982; Nolan, S. L. and A. K. Hop- 
per, unpublished observations).  However, there are distinc- 
tions between the RNA/gene and the PRP genes. The rna/-1 
mutation pleiotropically affects all classes of RNA, tRNA at 
the step of removal of intervening sequences (Knapp et al., 
1978; Hopper et al., 1978), ribosomal RNA at the step of 
processing the primary transcript (Hopper et al., 1978), and 
all mRNAs at a step(s) that is not well described (Hutchison 
et al., 1969; Shiokawa and Pogo, 1974; St. John and Davis, 
1981). A recent study shows that the poly(A) tails of  mRNAs 
generated at the nonpermissive temperature are increased in 
length (Piper and Aamand,  1989). The rna/-1 mutation also 
affects transport  of RNA from the nucleus  to the cytosol 
(Hutchison et al., 1969; Shiokawa and Pogo, 1974), although 
this may be a secondary consequence  of RNA processing 
defects. Conversely, mutations of PRP loci do not appear to 
affect pre-tRNA  splicing (Hopper, A. K., unpublished  re- 
suits) and affect only mRNAs coded for by genes that contain 
an intron (Rosbash et al., 1981). Because the rna/-1 mutation 
causes pleiotropic defects in RNA production,  it has been 
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several RNA processing reactions, a regulator of genes cod- 
ing for processing products,  or might be  involved in the 
general structure of the nucleus (Hopper et al., 1980; Atkin- 
son et al.,  1985). 
One approach to understanding the role of RNA/in RNA 
processing pathways is to localize the RNAI protein in yeast. 
Based upon the proposed models of the RNA1 protein func- 
tion, we expected this gene product to be found exclusively 
within the yeast nucleus and perhaps near the inner nuclear 
membrane. In previous studies we cloned (Atkinson et al., 
1985) and sequenced (Traglia et al., 1989) the RNA/gene. 
This work provided the tools and information to generate 
anti-RNA1  sera.  Using  such  antisera,  we  show  that the 
RNA1 protein is present in the cytoplasm and appears to be 
excluded from the nuclear compartment. These results are 
unexpected and have forced us to reevaluate the models of 
RNA1  function in RNA processing. 
Materials and Methods 
Strains, Media, and Genetic Methods 
The yeast strains used in this study are described in Table I. These strains 
were grown in either YEPD, complete minus uracil or complete minus ura- 
cil and leucine,  formulated as described previously (Hurt et al.,  1987). 
Bacterial strain RR1  (F- pro leu thi lacY Str  r r-k m-k hsdR hsdM endol) 
was used for all manipulations except for construction of the OmpF-RNA/- 
LacZ fusion.  To generate this plasmid, Escherichia ~oli strains MH3000 
and TK1046 were used as described by Weinstock et al.  (1985).  L-broth 
and YT-amp solid media were formulated as described previously (Maniatis 
et al.,  1982). 
Yeast cells and bacteria were transformed according to the method of Ito 
et al.  (1983) and Maniatis et al.  (1982) respectively. 
DNA Manipulations and Plasmid DNAs 
Restriction endonucleases (Bethesda Research Laboratories, Inc., Gaithers- 
burg,  MD;  New England Biolabs, Inc., Boston, MA; Boehringer Mann- 
helm Biochemicals, Indianapolis, IN) were used as prescribed by the manu- 
facturers. Ligations using T4 DNA ligase (Bethesda Research Laboratories) 
were carried out in the buffer supplied by the manufacturer at 23"C for 4 h. 
A  variety of yeast/E,  coli shuttle vectors were employed.  YEp24 is a 
UK43-contalning vector that achieves multiple copies in yeast (Botstein et 
al., 1979). YEpRNA1 and YEprnal-1 are derivatives of YEp24 that contain 
genomic fragments encoding the wild-type R/CA/and mutant rna/-1 alleles, 
respectively (Atkinson et al.,  1985). YCpRNA1 is a CEN3-containing sin- 
gle or low copy plasmid that harbors genomic RNA/  sequences;  YEpc- 
RNA(I.4) was derived from pMac561, a TRPl-containing multicopy vector 
with a cDNA encoding RNA/regulated by the ADH1 promoter (Atkinson 
et al.,  1985).  YEpcRNA  (1.4) leads to high expression of RNA/in yeast 
cens. pFB1-7a and pFB1-67a are multicopy plasmids that contain the yeast 
LEU2 gene and gene fusions of sequences encoding yeast historic H2B 
(H2B2) and E. ¢oli fl-galactosidase (Moreland et al.,  1987). pFB1-7a con- 
tains 7  codons of H2B2  fused in-frame to LacZ and encodes a  H2B-/~- 
galactosidase chimeric protein that is located in yeast cytoplasm; pFB1-67a 
contains 67 codons of H2B2 fused in-frame to LacZ and encodes a chimeric 
protein that translocates to yeast nuclei (Moreland et al.,  1987). 
YEpRNAI(1-187)/LacZ was derived from pFB1-7a as diagrammed in Fig. 
1, A and B.  The H2B2-containing fragment of pFB1-7a  was removed by 
digestion with Sma I and Barn HI. A  region extending from a Dra I site 
upstream of the RNA/ORF to a Barn HI site at codon 187 was ligated into 
the Sma I-Barn HI-digested pFB1-7a.  This created an in-frame fusion of 
RNA/to LacZ. 
pORF1-RNA1, a derivative of pORF1 (Weinstock et al.,  1983) contains 
in-frame fusion ofE. coli OmpF, an internal portion of the yeast RNA/gene, 
and LacZ.  To generate pORF1-RNA1 a Dpn I-Hint II restriction fragment 
from an RNA/-containing plasmid was inserted into pORF1 at the Sma I site 
(Fig.  1, B and C). 
Protein Extraction and Blot Analysis 
To purify the OmpF-RNAl-fl-galactosidase trihybrid protein, pORF1-RNA1 
was transferred to E.  coil strain TK1046 that has the OmplL:s allele. Tri- 
hybrid protein production was induced by temperature shift from 25 to 42°C 
as described by Weinstock et al. (1983). The OmpF-RNA1-/~-galactosidase 
hybrid protein was extracted from 500 ml of culture as described by Last 
and  Woolford  (1986)  except  that  the  purification  was  terminated  after 
resuspension and boiling of the 2 % Triton X-100 washed pellet. As deter- 
mined by SDS-PAGE analysis the vast majority of protein at this step was 
the desired fusion protein (data not shown). 
Yeast cell protein extracts were prepared by modifications of the proce- 
dures described by Hopper et al. (1974) or Schultz et al. (1987) as indicated 
in the figure legends. Protein blot analysis followed the procedure of Towbin 
(1979). 
Table L Yeast Strains 
Strain  Genotype  Description/Source 
A364a  MATa gall adel ade2 ural his7 tyrl lys2  L.  Hartwell;  parent ts136:  the original  strain containing 
rnal-1  (Hutchison et al.,  1969) 
SJ17  J.E.  Hopper 







MATc~ ura3-52 leu2-3,  112 gal4 his4 
rnal-1  trpl-1 (MAT,  leu,  his, ura and 
gal not tested) 
MATa rnal-1  ura3-52 adel try1 his7 his4 Gal- 
MATa RNA1  rnh  l : : URA3 ura3-52 his7 
his4 adel tyrl Gal- 
MATa rnal-1  rnhl : : URA3 ura3-52 his7 
his4 adel tyrl Gal- 
MATa rna1-A397-407 rnhl ::URA3 his7 his4 
ura3-52 adel tyrl Gal- 
MATa rnal-A359-397 rnhl : :URA3 his7 his4 
ura3-52 adel  tyrl Gal- 
MATa/MATct,  ura3-52/ura3-52,  1eu2-3,112/ 
leu2-3,112,  rna  l-1/rna  l-1,  tyr  l /TYR1, 
His-/His ÷,  Gal-,  Ade- 
Atkinson et ai.,  1985;  derived  from  SJ17 and ts136 
Traglia et al.,  1989;  derived  from EEIb by gene replacement 
Traglia et al.,  1989;  derived  from EElb by gene replacement 
Traglia et al.,  1989;  rnal-A397-407 allele is a  deletion of 
codons corresponding  to the peptide  used to generate 
antipeptide  sera;  derived  from EElb by gene replacement 
Traglia et al.,  1989;  rnal  allele is a  deletion of codons 359-397 
that causes temperature-dependent  lethality;  derived  from 
EElb by gene replacement 
Atkinson et al.,  1985;  derived  from SJI7  and ts136 
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Figure L Strategies  for generating  RNA1-LacZ and OmpF-RNA1- 
LacZ chimeric genes. (A) Restriction map of pFB1-7a, a yeast shut- 
tle vector that contains the regulatory region and codons for the first 
seven amino acids for bistone H2B (-) fused in-frame to LacZ (5) 
(Moreland et al.,  1987).  Lines from Fig.  1, A and B  indicate the 
Dra I to Bam HI restriction fragment from the RNA/locus (B) that 
was  used  to  replace  the  H2B2-containing  fragment  deleted  by 
digestion of pFB-1-7a by Sma I and Barn HI. The resulting plasmid 
is YEpRNAl(M87)/LacZ.  (C) Restriction map of pORF1  (Wein- 
stock et al.,  1983).  Lines extending from Fig.  1, B  to C  indicate 
the Dpn I/Hinc 11 fragment from RNA1  that was  inserted at the 
Sma I site of pORF1  to generate in-frame fusions with OmpF (~) 
upstream  and  LacZ  (5)  downstream.  The  resulting plasmid  is 
pORF1-RNA1  ([]) indicates sequences encoding  ampicillin resis- 
tance. Restriction sites: A, Ava I; B, Bam HI, C, Hinc 11; D, Dra I; 
E, Eco RI; H,  Hind 11I, L, Cla I; M, Sma I; N, Dpn I (There are 
multiple Dpn I sites in RNA/and only one is indicated); P, Pst I; 
S, Sst I; X, Xba I. For A and C, only the restriction sites relevant 
to generating the construction are indicated. ATG and TAG indicate 
the beginning and end of the RNA/  ORE 
Cell Fractionation 
Yeast cells were fractionated by a modification  of the method described by 
Silver et al. (1984).  300 ml of 2b x  3b cells containing YEp24 and pFB 
1-67a or YEpRNA1 and pFBI-67a were grown to early log-phase in media 
lacking leucine and uracil. The cells were collected at 5,000 g for 10 min 
and were resuspended in 8 ml of 1 M sorbitol, 20 mM K2HPO4-KH2PO,,, 
pH 6.5, 0.5 mM CaCl2, 0.5% 2-mercaptoethanol, 0.5 mM PMSE and the 
cell walls were removed by digestion at room temperature with Zymolyase- 
20T (Seikagaka Kogyo Co., Tokyo, Japan) at a final concentration of 0.25 
mg/mi. Spheroplasts  were collected by centrifugation at 3,500 g for 3 rain 
and were resuspended in 2 ml of 0.2%  NP-40,  10 mM Tris-HCl, pH 7.4, 
10 mM NaC1, 5 mM MgC12, 0.5 mM CaCl2, 0.5 mM PMSE The sphero- 
plasts were lysed and homogenized in a Dounce homogenizer until nearly 
all cells appeared broken as determined by light microscopy. A fraction of 
this lysate was saved and used as a source of total cell protein. Nuclei from 
the lysed cells were collected by centrifugation at 3,000 g for 5 rain. The 
supernatant was saved and used as a source of cytoplasm-enriched proteins. 
The pellet fraction was resuspended in 30 mi of 50% (wt/vol)  Percoll,  40 
mM Pipes, pH 6.8, 10 mM MgCI2, 0.5 mM PMSF,  0.05%  Triton X-100 
and centrifuged at 21,000 g for 35 rain in a rotor (model SS34; Sorvall Div.). 
The nuclear band was  removed  from the gradient, diluted  10-fold with 
0.01 M K2HPOa-KH2PO4, pH 6.5 and nuclei were collected by centrifuga- 
tion at 5,000 g for 5 min. This pellet was resuspended in 300 t~l gel loading 
buffer (Schultz et al.,  1987) and served as the source of nuclear proteins. 
Antisera 
The following antibodies were obtained commercially: rabbit anti-E,  coli 
/~-galactosidase  IgG (Cappel Laboratories/Cooper Biomedical, Malvern, 
PA); mouse anti-E,  coli/~-galactosidase (Promega Biotec,  Madison, WI); 
alkaline phosphatase-conjugated  affinity-purified goat anti-rabbit IgG, heavy 
plus light-chain specific (Cappei Laboratories/Organon Teknika and Pm- 
mega Biotec); FITC-conjugated  affinity-purified goat anti-rabbit IgG (Cap- 
pel Laboratories/Organon Teknika); and rhodamine-conjugnted goat anti- 
mouse IgG (Boehringer Mannheim Biochemicals, Indianapolis, IN). All 
commercial antibodies were used as supplied except for rabbit anti-/3-galac- 
tosidase that was affinity-purified  before use (see below). 
Antisera specific to the RNA1 protein were prepared by Pocono Rabbit 
Farm and Laboratory (Canadenasis, PA).  To  generate sera against the 
OmpF-RNA143-galactosidase  trihybrid fusion protein, 50/~g of the semi- 
purified preparation were injected into two rabbits subcutaneously on day 
0 and at 4 wk.  The rabbits were inject~ intravenously at 6 wk and sub- 
cutaneously at 14 wk with 10/~g of the protein preparation. The serum ob- 
tained from a final bleeding at 16 wk of rabbit 5154 was used for the experi- 
ments described. 
To generate sera against the RNA1 COOH-terminal peptide,  a synthetic 
peptide  of sequence GDLAERLAETEIK conjugated to dipalmityl lysine 
carrier (Hopp,  1984) was synthesized by Biosearch (San Rafael, CA). 5 mg 
of this preparation were injected intradermaUy into two rabbits at day 0. At 
2 wk,  1 mg was injected intradermally.  At 4 wk and 8 wk,  1 mg of con- 
jugated peptide was injected subcutaneously.  The serum obtained from a 
bleeding of rabbit 6142 at 10 weeks was used for the studies reported here. 
Anti-/~-galactosidase and anti-OmpF-RNA-/$-galactosidase sera were affin- 
ity purified  (Livingston, 1974).  CNBr-Sepharose 4B was coupled to the 
protein ligand as described by Pharmacia Fine Chemicals (Piscataway, NJ). 
Chromatography proceeded as described by Kilmartin and Adams (1984). 
The serum from rabbit 6142 could be used directly in immunofluores- 
cence studies to detect amplified  levels of RNAI antigen.  However, using 
this serum we were unable to distinguish staining of cells processing an en- 
dogenous  RNA gene from the staining of cells possessing  a deletion of the 
epitope.  To improve sensitivity,  the serum was purified  by preadsorption. 
The cell walls from 10 ml of log-phase formaldehyde-fixed EElb-A397-407 
cells were removed by digestion with Glusulase and Zymolyase 5000 (see 
immunofluorescence,  below). The spheroplasts  were resuspended  in 1.0 ml 
0.73 mM KH2PO4, 145 mM NaCl, and 0.1% BSA. Antiserum was mixed 
with the resuspended fixed spheroplasts at a dilution of 1/100 and incubated 
with agitation for 4 h at 4°C.  The cells and debris were subsequently re- 
moved from this pre-adsorbed serum by centrifugation. The specificity and 
titre of the pre-adsorbed antisera was verified by protein blot analysis (not 
shown).  Preadsorbed sera could be used to detect endogenous levels of 
RNAI  antigen via immunofiuorescence. 
Indirect lmmunofluorescence 
Indirect immunofluorescence  experiments were carried out by modifica- 
tions of the procedure described by Kilmartin and Adams (1984) and More- 
land et al. (1987) and recently described in detail (Li et al., 1989). Variations 
upon this procedure for triple labeling experiments or to study heat-depen- 
dent location of RNA1 antigen are given in the figure legends. 
Results 
Three approaches were taken to obtain antisera useful for 
determining the intracellular location of the RNA1 protein. 
One approach was to generate RNA1-LacZ gene fusions that 
could be expressed in yeast. Antisera directed against ~-ga- 
lactosidase was used to locate the chimeric protein. A sec- 
ond approach was to construct a OmpF-RNAI-LacZ  gene fu- 
sion that could be expressed in E. coli. This trihybrid protein 
could then be purified from E. coli  and used to generate anti- 
RNA1 sera. The third approach was to use a synthetic pep- 
tide corresponding to a hydrophilic region of the RNA/ORF 
to obtain rabbit sera specific to this peptide. 
RNAl-[3-Galactosidase Fusion Protein Is Apparently 
Excluded  from Yeast Nuclei 
Parts  of genes  encoding  proteins  that  are  targeted  to or- 
ganelles have been fused to genes encoding passenger pro- 
teins. These fusions have been useful in yeast to determine 
the location of the first product as well as to map targeting 
Hopper et al.  Cytoplasmic Location for RNA1 Protein  311 Figure 2. Indirect immunofluorescence using/$-galactosidase antibody. Cells were grown under selective conditions and were prepared 
for indirect immunofluorescence as described in Materials and Methods. (A and B) Yeast strain SJ17 harboring pFB1-67a that encodes 
a histone 2B-/~rgalactosidase  protein targeted to nuclei (Moreland et al., 1987). (Cand D) Yeast strain SJ17 harboring pFBI-7a  that encodes 
a histone 2B-/~-galactosidase  protein unable to translocate to yeast nuclei (Moreland et al., 1987). (E and F) Yeast strain SJ17 harboring 
YEpRNAl(1-187)/LacZ that encodes a fusion protein containing the first 187 amino acids of RNA1 fused in-frame to LacZ. A, C, and 
E cells stained with DAPI to show location of nuclei. B, D, and F cells stained with 1/100 dilution of affinity-purified  anti-/$-galactosidase 
IgG as primary antibody and 1/100 dilution affinity-purified FITC-conjugated goat anti-rabbit  IgG as secondary antibody. 600×. Bar, 
10 gm. 
information. For example, the E.  coli LacZ gene has been 
used successfully for Studies  of mitochondrial (Douglas et 
al.,  1984) and nuclear (Hall et al.,  1984) targeting in yeast. 
We used gene fusions of RNA/to LacZ to study the loca- 
tion of the RNA/gene product. These fusions used plasmid 
pFB1-7a (Moreland et al.,  1987). pFB1-7a is an E. coli/yeast 
multicopy shuttle vector in which the histone H2B regulatory 
region  directs  synthesis  of a  histone-B-galactosidase chi- 
meric protein containing seven amino acids of histone H2B. 
The H2B2 sequences of pFB1-7a were substituted by RNA/ 
sequences to generate YEpRNAl(1-187)/LacZ. YEpRNAl(1- 
187)/LacZ contains the RNA/regulatory region and codons 
for the first 187 amino acids fused in-frame with LacZ (see 
Materials and Methods and Fig.  1). 
Yeast strain SJ17 (relevant genotype: leu2-3,H2) harboring 
YEpRNAl(1-187)/LacZ  produces  /3-galactosidase  antigen. 
The vast majority of the antigen was of the electrophoretic 
mobility expected for an RNA1-/3-galactosidase chimeric pro- 
tein as determined by protein blot analysis (not shown). 
We used indirect immunofluorescence using affinity-puri- 
fied rabbit anti-/~ galactosidase and FITC-conjugated aflin- 
ity-purified goat anti-rabbit antibody to localize the fusion 
protein  within  yeast.  Yeast  containing a  related plasmid, 
pFB1-67a, containing the first 67 amino acids of  histone H2B 
(Moreland et al.,  1987) show subcellular staining to a com- 
partment that also stains with DAPI, a stain specific to DNA 
(Fig.  2, A and B).  As the nuclear targeting sequences for 
yeast histone H2B are between amino acids 28-33, the nu- 
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protein. (A) Analysis using affinity puri- 
fied anti-RNA1 sera raised  against the 
OmpF-RNAl-fl-galactosidase  trihybrid 
fusion protein. Yeast strains were grown 
under selective conditions to log phase. 
Lysates were prepared by a variation of 
the  procedure  described  by Hopper et 
al. (1974). Ceils were broken by homog- 
enizing the following mixture four times 
for 15 s: 0.2 ml cells at '~1  x  109 cells 
per ml in 0.0625 M Tris(hydroxymeth- 
yl)arnino methane (pH 6.8), 5 % mercap- 
toethanol  3%  SDS, 0.3  mg PMSF per 
ml,  and 0.5  ml glass  beads  (0.45 mm 
diameter).  Cells  were  eluted  from the 
beads by three washes with 0.2 ml of the same buffer, immediately boiled for 3 min and frozen at -20°C.  Proteins were resolved on a 
5 % stacking,  10% running SDS polyacrylamide gel. The blot was blocked, reacted with a 1/50 affinity-purified antifusion protein antibody, 
washed and then reacted with alkaline phosphatase-conjugated  affinity-purified goat anti-rabbit IgG at 1/1,000 dilution. Lanes: 1, wild-type 
strain A364a; 2, strain AKHI008 (rnal-1 trpl-1  ); 3, strain AKHI008 containing vector pMac561; 4, strain AKH1008 with YEpcRNAI(1.4). 
(B) Analysis using anti-RNA1 COOH-terminal  peptide.  Cells were grown to midlog phase under selective conditions. If heat treatment 
was applied,  the culture was split and one-half of the culture was maintained at 23°C and the other half was transferred to 37°C. After 
1 h, the cells were quickly collected,  washed one time with 23 or 37°C water (as appropriate),  suspended in breaking buffer (Schultz 
et al.,  1987) and quickly frozen. Preparation of cell lysates was as described by Schultz et al., (1987) except that supernatant and pellet 
fractions were not separated.  Equal micrograms of proteins (except for lanes 4 and 5, which have twice the quantity) were loaded onto 
two 5% stacking/10% running  SDS polyacrylamide gels; one gel was stained with Coomassie blue and the proteins  on the other were 
electrophoretically  transferred  to membranes.  The blots were first reacted with  1/1,000 dilution of sera from rabbit 6142 and then with 
1/1,000 dilution of affinity-purified alkaline phosphatase-conjugated  goat anti-rabbit IgG. Lanes: 1, strain EElb-A397-407 that is missing 
the COOH-terminal epitope; 2, EElb harboring YCpRNAI (single copy plasmid containing RNA/); 3, EElb harboring YEpRNAI; 4, EElb- 
A359-397 (containing a detection causing temperature-sensitive  growth) incubated at the nonpermissive temperature  (37°C); 5, same as 
4 except ceils maintained  at permissive temperature;  6 and 7, EElb-6 (rna/-1)  grown at nonpermissive and permissive temperatures  re- 
spectively; 8 and 9, EElb-35 (RNAI) grown at 37 ° and 23°C, respectively. ---),  position of RNA1 antigen; ---), position of antigen produced 
by the deletion allele rnal-A359-397. 
clear location of the H2B1-67-/3-galactosidase fusion protein 
is consistent with previous studies (Moreland et al.,  1987). 
As previously reported, yeast containing the parental plas- 
mid pFB1-7a  that does not contain information for nuclear 
targeting show immunofluorescence staining in the cytosol 
(Moreland et al.,  1987),  but very little staining in the nu- 
cleus  (Fig.  2  D),  a  staining  pattern  we refer to  as "black 
holes" Because whole cells are used in these immunofluores- 
cence  studies  one  views the  nucleus  through  the  cytosol. 
Thus, even if there is no antigen in the nucleus, some staining 
is expected from the cytosolic contribution above and below 
the nucleus.  A similar staining pattern is seen for cells har- 
boring YEpRNAl(1-187)/LacZ. Although the cytosol stained 
intensely (Fig.  2 F), the nuclear region (Fig.  2 E) consis- 
tently possessed very little cross reactivity to anti-/3-galac- 
tosidase. That is, it appeared that the RNAl-fl-galactosidase 
fusion protein like the H2B1-7-fl-galactosidase fusion pro- 
tein,  was present in the cytosol, but not in the nucleus. 
It is possible that the RNA1-/3-galactosidase chimeric pro- 
tein is not localized to the same compartment as authentic 
RNA1 protein. The fusion may not have included sequences, 
should they exist, ofRNA/that would specify nuclear target- 
ing. Nuclear targeting sequences are not restricted to partic- 
ular regions of proteins and indeed some have been localized 
to the carboxy terminus (for review see DingwaU and Laskey, 
1986).  Alternatively, since the RNA1-LacZ sequences were 
contained on a multicopy yeast plasmid, overexpression of 
this sequence could lead to mislocalization in the cell. To ad- 
dress both of these problems we constructed chromosomally 
located fusions containing the entire RNA/  gene.  Unfortu- 
nately, such constructs expressed very low levels of ~-galac- 
tosidase and were insufficient  for immunofluorescence studies. 
Authentic RNAJ Protein Cannot be Detected in Nuclei 
by Indirect Immunofluorescence 
Due to problems in localizing the RNA1 protein by employ- 
ing  fusion  proteins,  we  sought  to  obtain  sera  that  would 
recognize authentic RNA1 protein. First, a RNA/fusion that 
could be expressed in E.  coli was generated.  The pORF1 
vectors are designed so that foreign sequences are inserted 
between bacterial OmpF and LacZ sequences such that trihy- 
brid fusion proteins are generated (Weinstock et al.,  1983). 
The OmpF sequences served to target the trihybrid protein 
to  the  bacterial  outer  membrane to  simplify purification. 
pORF1-RNA1 contains a Dpn I-Hinc II restriction fragment 
encoding  102 codons of the RNA/  gene (see Materials and 
Methods and Fig.  1).  This fragment was chosen because it 
would create in-frame fusions with both OmpF and LacZ se- 
quences and because the peptide was predicted to be hydro- 
philic (Kyte and Doolittle, 1982). The resulting plasmid was 
transferred to E. coli strain TK1046 that has the OmpRcs al- 
lele and  trihybrid protein production was induced  (Wein- 
stock et al., 1983). The trihybrid protein was purified to near 
homogeneity and used to inject rabbits. 
The serum from one rabbit, 5154, showed cross-reactivity 
with RNA1 protein when overexpressed. Proteins extracted 
from strain  A364a  (relevant genotype:  RNA/),  AKH1008 
(relevant  genotype rnal-1 trpl-1) or  AKH1008  containing 
vector (pMac561) sequences showed no cross-reactivity with 
the antibody (Fig.  3,  lanes 1, 2,  and 3).  However, proteins 
Hopper et al.  Cytoplasmic Location for RNA1 Protein  313 Figure 4. Indirect immunofluorescence using afffinity-purified  antibody generated against OmpF-RNA1-/~-galactosidase  fusion protein. (A) 
EElb cells stained with DAPI; (B) same ceils as in A, but treated with 1/100 affinity-purified  anti-RNA1 fusion protein primary antibody 
and 1/100 FYI'C-conjugated  affinity-purified  goat anti-rabbit IgG secondary antibody; (C) EElb containing YEpRNA1 treated with DAPI 
stain; (D) same cells as in C reacted with  1/100 anti-RNAl  fusion protein antibody and 1/100 FITC-conjugated affinity-purified goat 
anti-rabbit  IgG. 1,000×. Bar, 5 #m. 
from strain AKH1008 containing YEpcRNAI(1.4) that car- 
ries a cDNA copy ofRNA/inserted into pMac561 (Atkinson 
et al., 1985) showed a cross-reacting species at the molecu- 
lar weight calculated for the RNA/ORF (Fig. 3 A, lane 4). 
Therefore as analyzed by protein blot analyses of crude ex- 
tracts,  the  antisera  can  recognize the  RNA1  protein only 
when it is amplified in yeast cells. 
Serum 5154 was affinity-purified and used as the primary 
antibody for indirect immunofluorescence studies.  No RNA1- 
specific staining  could be detected when cells containing 
only the chromosomal rna/-1 allele were used (Fig. 4  B). 
However, the same antibody did stain cells harboring the 
multicopy YEpRNA1 plasmid. The staining pattern showed 
black holes (Fig. 4 D) in the nuclear region (Fig. 4  C) and 
was  indistinguishable from the pattern obtained using an- 
ti-/3-galactosidase to detect RNA/-/3-galactosidase  chimeric 
protein. Therefore, the results of studies using antibody to 
the authentic protein also indicated that the vast majority of 
RNA1  protein was  located in the cytosol. 
Although the antibody raised against the trihybrid protein 
allowed detection of the authentic RNA1 protein, it was not 
of sufficient titer to detect endogenous levels of protein from 
a chromosomal copy of RNA/.  Thus another strategy to ob- 
tain high-titer sera was tried.  Previously we reported that 
COOH-terminal codons 397-407 of the RNA/ORF were un- 
essential (Traglia et al.,  1989).  A  synthetic peptide corre- 
sponding to these codons was employed to raise anti-RNA1 
sera  for two reasons.  First,  this peptide corresponds to a 
hydrophilic COOH-terminal portion of the RNA/ORF (Kyte 
and Doolittle,  1982).  Second, if a high-titer sera was ob- 
tained, then yeast cells possessing an rna/allele deleted for 
these residues (i.e., rna1-A397-407) would generate protein 
lacking the  epitope of this  peptide  and,  therefore, would 
serve as a negative control for localization studies. 
The  peptide  GDLAERLAETEIK  was  used  to  obtain 
specific sera (see Materials and Methods). We used a con- 
genic set of strains to verify the specificity of sera from rab- 
bit 6142 and to localize the RNA1  antigen by indirect im- 
munofluorescence and organelle fractionation. Yeast strains 
EElb-A397-407, EElb-35, EElb-6, and EElb-A359-397 are 
variants of EElb (relevant genotype: rnal-1 ura3-52; Table 
I) that were derived by gene replacements. EEIb-A397-407 
harbors the rna/allele that is deleted for the COOH-terminal 
codons corresponding to the peptide used to generate the an- 
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contains the rna/-1  allele, and EElb-A359-397 possesses a 
deletion of codons 359-397  (Traglia et al.,  1989).  EElb 
strains containing YCpRNA1  and YEpRNN possess single 
(or low) copy and multicopy vectors (,x,5-20 copies),  re- 
spectively harboring genomic RNA/sequences. Strains that 
harbor YEpcRNAI(1.4), a highly expressed eDNA copy of 
RNA/, have also been employed and results analogous to 
those for YEpRNA1 were obtained (not shown). Proteins ex- 
tracted from cells harboring the rnad-A397-407 allele did not 
contain an antigen recognized by this sera (Fig. 3 B, lane 1). 
However,  proteins extracted from EElb-35  wild-type cells 
(Fig. 3 B, lanes 8 and 9) or EElb-6 cells harboring the rna/-1 
allele (Fig. 3 B, lanes 6 and 7) contained a cross-reacting 
species of the mobility expected for the RNA1 protein. This 
signal increased in intensity when strain EElb contained ei- 
ther low-copy YCpRNA1  (Fig.  3 B,  lane 2)  or multicopy 
YEpRNA1  (Fig. 3 B, lane 3) plasmids. Furthermore, pro- 
teins extracted from EElb-A359-397 cells possessing an in- 
ternal deletion of 38 amino acids, produces a signal at an ap- 
propriate lower molecular weight (Fig. 3 B, lanes 4 and 5). 
We conclude that serum from rabbit 6142 is specific for the 
RNA1 protein and of high titer. 
Preadsorbed 6142 serum was used for indirect immunoflu- 
orescence studies to localize the RNA1 antigen within yeast 
cells. Cells harboring the rna1-A  397-407 allele show very lit- 
tle FITC staining (Fig. 5 B). The faint staining that can be 
detected appears to be localized to the "cytosol and has a 
granular appearance.  We have been unable to completely 
eliminate the FITC signal in these negative control cells. 
Wild-type cells (Fig. 5 D) or cells harboring the chromo- 
somal rna/-1  mutation (not shown) show a staining pattern 
similar to that obtained in Figs. 2 and 4.  That is, there is 
staining of the cytosol but the nuclear region (Fig. 5 C) is 
devoid of FITC signal. Although the RNA1 antigen is spread 
throughout the cytosol, in some cells (arrows, Figs. 5, D and 
F) it appears to be concentrated around the nucleus. The sig- 
nal increases as the number of the RNA/copies increases 
(compare Fig. 5, D, F, and H). With increased RNA/copy 
number, the signal appears more disperse and the black holes 
become more prominent. We have evidenced cell to cell var- 
iation in staining of cells with both RNA1 and/~-galactosi- 
dase specific antibodies (also see Figs. 2 and 6). Presumably 
this is due to variation in plasmid copy number, plasmid loss, 
and differential permeability of the cells to antibody. 
To be certain that the region devoid of signal was the nor. 
cleus, we employed triple labeling procedures. Diploid strain 
2b x  3b (relevant genotype; rnal-1/rnal-1, ura3-52/ura3-52, 
leu2-3, 112/leu2-3, 112) was transformed with two plasmids: 
either YEp24 vector containing the URA3 gene and pFB1- 
67a that contains the histone H2B1-67-LacZ fusion and the 
LEU2 gene or YEpRNA1  containing the RNA/ and URA3 
genes in combination with pFB1-67a. Cells were first stained 
with preadsorbed  rabbit  anti-RNA1  peptide antibody and 
affinity-purified mouse anti-/3-galactosidase and then with 
FITC-conjugated goat anti-rabbit IgG and rhodamine-con- 
jugated goat anti-mouse IgG. The cells were also stained 
with DAPI. The region devoid of FITC (RNA1) stain appears 
larger than the region stained by DAPI (compare Fig. 6, A 
and D to C and F) as if the DNA does not occupy the entire 
nucleus. However, rhodamine (histone-/3-galactosidase)  stain 
occupies nearly the entire region not stained by FITC (com- 
pare in Fig. 6, B and E to C and F). Thus FITC and rhoda- 
mine stain mutually exclusive regions of the yeast cell. We 
conclude that the region apparently depleted of RNA1 anti- 
gen is the nucleus. 
RNA Antigens Do Not Fractionate with Nuclei 
Cell fractionation was used to obtain an independent assess- 
ment of the subceUular location of the RNA1 protein. Two 
yeast strains were used. The first strain is the variant of the 
diploid 2h  ×  3b that contains pFB1-67a,  harboring LEU2 
and 67 codons of H2B2 fused in-frame to LacZ, and vector 
YEp24 harboring URA3. The second strain is the 2b  ×  3b 
variant containing pFB1-67a and the RNA1 multicopy plas- 
mid, YEpRNA1, instead of YEp24.  Proteins from cell ly- 
sates and semipurified nuclei (see Materials and Methods) 
from the yeasts were resolved by SDS-PAGE and transferred 
to nitrocellulose membranes. The membranes were incubated 
with rabbit antibodies specific to/3-galactosidase, the COOH- 
terminal peptide of the RNA1 protein or the RNA1 region 
incorporated into pORF1-RNA1. Alkaline phosphatase-con- 
jugated goat anti-rabbit IgG was used as the secondary anti- 
body. As can be seen in Fig. 7 A, lanes 6-8 and 10-12 and 
Fig. 7 B, lanes 6-8,  semi-purified nuclear fractions, cyto- 
plasm-enriched fractions, and total cell extracts all contain 
/~-galactosidase  antigen. Fig. 7 A also shows the fraction- 
ation of endogenous levels of RNA1 protein as detected by 
the anti-peptide serum from rabbit 6142.  The cytoplasm- 
enriched fraction (lanes  3  and 1/)  and total cell extracts 
(lanes 4 and 12) contain antigen, but there is no antigen de- 
tected in the purified nuclear fraction (lanes 1 and 10). Fig. 
7 B shows the location of the RNA1 antigen recognized by 
the antibody raised to the protein encoded by pORF1-RNA1. 
Because this antibody does not detect endogenous levels of 
RNA1 antigen, the cells used for these fractionation studies 
contained a  multicopy plasmid harboring the RNA/  gene. 
Consistent with the results in Fig. 7 A, the antibody to the 
OMPF-RNA1-/3-galactosidase  fusion  protein  can  detect 
RNA1 antigen in cytoplasm-enriched fractions, and total cell 
extracts, but not in the nuclear fraction. Therefore, as as- 
sessed by two different RNAl-specific antisera, the location 
of endogenous or overproduced levels of the RNA1 protein 
in subcellular fractions is cytoplasmic; no nuclear form of 
the RNA1 antigen was detected in these studies. Thus, the 
results of the cell fractionation studies confirm the results ob- 
tained by indirect immunofluorescence. 
The RNA1 Antigen Does Not Change SubceUular 
Distribution in Response to Heat Shock 
There is precedence for proteins relocating within cells un- 
der certain stress conditions (Baeuerle and Baltimore, 1988; 
for review see Lindquist, 1986).  We applied stress condi- 
tions to the yeast cells to determine if RNA1 protein would 
translocate to a different subcellular location. Fig. 8 shows 
the results of a treatment of cells for 50 rain at 37°C. As ex- 
pected, cells possessing the rnal-A397-407 COOH-terminal 
deletion allele show very little cross-reactivity with the pre- 
adsorbed antipeptide serum (Fig. 8, A and B). The location 
of wild-type RNA1 protein is similar for cells grown at 23°C 
and heat treated cells (Fig. 8, E and F). Even though by pro- 
Hopper et al. Cytoplasmic Location for RNA1 Protein  315 Figure 6. Indirect immunofluorescence employing anti-/~-galactosidase  and anti-RNA1 COOH-terminal peptide affinity-purified  antibodies. 
Yeast strain 2b x  3b harboring both pFB1-67a (H2B/~gal fusion) and YEpRNA1 were grown in complete minus uracil and leucine medium 
to middle log phase, fixed, and prepared for immunofluorescence (see Materials and Methods). The cells were stained with 1/200 dilution 
affinity-purified, mouse anti-/$-galactosidase  and 1/100 dilution of preadsorbed 6142 serum as primary antibodies. 1/200 dilution of rhoda- 
mine-conjugated goat anti-mouse IgG and 1/200 dilution FITC-conjugated goat anti-rabbit IgG were used as secondary antibodies. After 
staining with the first and second antibodies, the cells were stained with DAPI. A, DAPI stain; B, rhodamine stain; C, FITC stain; D, 
E, and F,, same as for A, B, and C except that a different field was photographed. 600×.  Bar,  10 #m. 
Figure 5.  Indirect immunofluorescence using prcadsorbed anti-RNA1 C-terminal peptide from rabbit 6142.  (.4) EElb-A397-407 cells 
(deleted for the COOH-terminal peptide) with DAPI stain; (B) EElb-A397-407 cells reacted with 1/100 6142 antibody; (C and D) EElb-35 
(RNA1) cells stained as in A and B; E and F, EElb cells harboring YCpRNAI ('M copy/cell) stained as A and B; (G and H) EEIb cells 
harboring YEpRNA1 (5-20 copies/cell) stained as for A and B. The photographs for B, D, and F were all exposed and developed for the 
same time. H was exposed less time to accommodate the more intense staining. 600x.  Bar,  10 #m.  Arrows in D and F  point to cells 
that show apparent preferential staining around the nucleus. 
Hopper et al. Cytoplasmic  Location for RNAI Protein  317 Figure 7.  Location of RNA1 antigen in subcellular 
fractions. Cell fractions were prepared from 2b x  3b 
containing YEp24 (vector alone) and pFB1-67a (A) or 
2b  ×  3b containing YEpRNA1 and pFBI-67a (B). 
Each panel contains four lanes: the first lane contains 
prestained fumarase, a protein of similar mobility to 
the RNA1 protein; the second lane contains proteins 
from semipuritied nuclei (see Materials and Meth- 
otis); the third lane contains proteins from a cyto- 
plasm-enriched fraction (see Materials and Methods); 
and the fourth lane contains total cell extracts. Note 
that the nuclear fraction contains about one-tenth the 
amount of  proteins as do the other two fractions. Pro- 
teins  were resolved on a  5%  stacking/8%  running 
SDS polyacrylamide gel (Laemmli, 1970). The pro- 
teins were transferred by electroelution to nitrocellu- 
lose. The  blots were preincubated for  4 h at room tem- 
perature in NET buffer (0.15 M NaCI, 5 mM EDTA, 
50 mM Tris-HCl, pH 7.4, 0.25% gelatin, 0.05% NP- 
40, 2 % BSA). The blots were incubated with 5 ml of 
the following antibodies: (A) lanes 1-4, 1/5,000 dilu- 
tion in NET buffer of 6142 antisera,  specific to the 
RNA1 COOH-terminal peptide; lanes 5-8,  1/5,000 
dilution afffinity-purified  rabbit anti-/3-galaetosidase; 
lanes 9--12, 6142 serum plus anti-#-galactosidase; (B) 
lanes 1-4,  1/250 dilution affinity-purified anti-RNAl sera raised against the OmpF-RNAl-/3-galactosidase trihybrid fusion protein, lanes 
5-8, 1/5,000 dilution affinity purified anti-13-galactosidase. The blots were washed four times with PBS plus 0.1% NP-40 and 0.1% BSA. 
The blot was then incubated with 1/5,000 dilution in NET buffer of at~inity-purified  alkaline phosphatase-conjugated goat anti-rabbit IgG 
washed four times and then developed to detect the location of alkaline phosphatase (Towbin et al.,  1979). 
tein blot analysis we can detect no difference in rnal-1 protein 
in cells grown at 23°C or treated for 50 min at 37°C (Fig. 
3 B, lanes 6 and 7), by immunofluorescence we detect very 
little rnal-1 protein after heat shock (Fig. 8, C and D). How- 
ever, in no case have we been able to detect a nuclear location 
for wild-type or mutant RNA1  proteins. 
Discussion 
The RNA1 protein was expected to be localized in the yeast 
nucleus for two reasons: (a) the rna/-1 mutation is known to 
affect only nuclear processes, pre-tRNA and pre-rRNA pro- 
cessing, mRNA production, and RNA export to the cytosol; 
and (b) wild-type counterparts of other genes that generate 
mutant phenotypes similar to rna/-1 encode nuclear-local- 
ized proteins.  However, by using  indirect immunofluores- 
cence and organelle fractionation studies, we have been un- 
able to detect any RNA1 antigen within yeast nuclei. Rather, 
the antigen is located in the cytosol with only a hint of prefer- 
ential concentration on the periphery of nuclei. 
There are several possible interpretations of our results. 
First, one could propose that the majority of RNA1 protein 
is localized in yeast nuclei, but is in a cryptic form not recog- 
nized by any of our antisera.  This possibility  is  unlikely 
because by using three different antisera to the RNA/-13-ga- 
lactosidase fusion, the RNA1 peptide included in the pORF1- 
RNA1 fusion, and the COOH-terminal region, we have sam- 
pied a large portion of RNA1  product. Furthermore, using 
two different methods for detection of protein, immunofluo- 
rescence and PAGE analyses,  we obtain the same results. 
It seems unlikely that none of these antisera and methods 
would have detected a cryptic form of RNA1 protein, should 
it exist. 
Second, one could propose that the majority of RNA1 pro- 
tein is localized to nuclei only under special conditions. Such 
is the case for other gene products such as heat-shock pro- 
teins that translocate to nuclei under certain temperature re- 
gimes (for review see Lindquist,  1986) and NF-kB, a DNA 
binding protein, that translocates to the nucleus upon treat- 
ment of cells with phorbol esters (Baeuerle and Baltimore, 
1988). Since rna/-1 and rnal-A359-397, cause heat-sensitive 
growth (Hutchison et al.,  1969;  Traglia et al.,  1989),  we 
used a heat-shock regime to determine whether wild-type or 
mutant RNA1 protein might become localized to the nucleus 
at elevated temperatures. The location of protein encoded by 
the wild-type RNA/allele is not temperature dependent. The 
protein encoded by the mutant rna/-1 allele, was barely de- 
tectable by immunofluorescence after incubation of the mu- 
tant cells for 1 h at the nonpermissive temperature. It is not 
known why protein encoded by rna/-1 is not detected at high 
temperatures. However, it is possible that the mutant rnal-1 
protein is denatured at high temperatures so that it cannot be 
recognized by antibody unless it is unfolded by the condi- 
tions used for PAGE analysis. Alternatively the protein may 
be unstable and degraded before it is fixed by formaldehyde. 
There is evidence of cellular redistribution of gene products 
at  specific points  in  the  cell cycle (for review see Hunt, 
1989). It is unlikely that the RNA/protein is located in nuclei 
only at specific points in the cell cycle because we have used 
nonsynchronous populations of cells; regardless of bud size 
the RNA1 antigen is located in the cytosol. It could be argued 
that the wild-type RNA1 protein might translocate to the nu- 
cleus upon some heretofore untested condition.  Although 
this remains a formal possibility, it seems unlikely because 
the RNA1  protein is an essential product that is needed for 
normal mitotic growth (Atkinson et al.,  1985). 
The Journal  of Cell Biology,  Volume 111, 1990  318 Figure 8.  Location of the RNA1 antigen after heat-shock treatment. 20-ml cultures of EElb-A397-407, EElb transformed with YEprnal-1 
and EElb transformed with YEpRNA1 cells in complete minus uracil medium were grown to early log phase. The cultures were split 
into two equal volumes. One half was maintained at 23°C and the other half was shifted to 37°C. 50 rain later, the cells were quickly 
collected by centrifugation, resuspended in 23 or 37°C buffer,  as appropriate and fixed with formaldehyde. Heat-shocked ceils were fixed 
for 90 min at 30°C (a nofipermissive temperature for rna/-1;  higher temperatures resulted in poor antigen staining for all cells including 
/5-galactosidase controls). Cells grown at 23°C were fixed for 2 h at room temperature. Immunofluorescence proceeded as described in 
Materials and Methods. (A) EElb-A397-407, 23°C; (B) EEIb-A397-407, 37°C for 50 min; (C) EElb plus YEprnal-1, 23°C; (D) EElb with 
YEprnal-1, 37°C,  50 rain; (E) EElb with YEpRNAI, 23°C;  (F) EElb plus YEpRNA1, 37°C,  50 min. 
Hopper et al. Cytoplasmic Location for RNA1 Protein  319 Third, it is possible that a small percentage of the RNA/ 
gene product is localized to the nucleus and performs an es- 
sential function there. Even though we have been unable to 
locate any RNA1 protein in the nucleus we cannot conclude 
that a small fraction of the RNA1 protein, beyond our means 
of detection, does not reside in this compartment. There is 
precedence for proteins that are dually located in the nucleus 
and the cytosol with the majority of the protein residing in 
the  cytosol.  Ribosomal  proteins  are  one  such  example. 
These proteins are structural components of cytosolic ribo- 
somes, but also translocate to nuclei where they participate 
in ribosome assembly (for review see Warner,  1989).  The 
RNA1 protein could also have such a dual function. For ex- 
ample, it could serve as a "chaperon" to target RNA out of 
the nucleus or to target components essential for pre-RNA 
processing into the nucleus. 
Among the possible explanations for our data we favor 
models based on the premise that the major function of the 
RNA1 protein is where the majority of the antigen is located; 
that is, it is most likely that RNA1 protein functions in the 
cytosol. How might a cytosolic protein affect production and 
nuclear export of RNA? The RNA1  protein might modify 
and  thereby  regulate  nucleus-targeted proteins  or  might 
otherwise be  involved in  transmitting  a  signal  from the 
cytosol to the nucleus. If the RNA1 protein is involved in 
modification of nuclear proteins,  the  modification would 
need to be short lived, as the pre-RNA processing defect of 
rna/-1  cells is detected shortly after shift to nonpermissive 
temperature (Hutchison et al.,  1969;  Shiokawa and Pogo, 
1974; Hopper et al., 1978).  The RNA1 protein could serve 
as a cytoplasmic anchor that holds "nuclear" proteins in the 
cytosol until needed (for review see Hunt,  1989).  In this 
case, also, one would need to propose that the quantities of 
RNA processing activities be tightly controlled in order to 
accommodate the rapid defect of rnal-1 cells. The RNA1 pro- 
tein could also be involved in the integrity of nuclear struc- 
ture. Alteration of the nuclear membrane would be expected 
to  have pleiotropic consequences upon RNA metabolism 
and hence such a model could accommodate the pleiotropic 
defects in RNA metabolism inherent in rna/-1  cells. 
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